Price
No data yet.
Social Signal Score
Revenue
$0.00Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- A. Rachel Leheny
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 16
- Beta
- 1.12
- Country
- US
- Piotroski score
- 3 / 9 (Weak)
- Altman Z-score
- -15.78
Financials
Net Income
$-7.65MEBITDA
$-7.32MFree Cash Flow
$-4.62MEPS (diluted)
$-0.45Shares Outstanding (diluted)
17.10M+1555.3%Operating Expenses
$4.01MCash & Debt
$18.62MQuote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $0.00 | $-29.56M | $-1.97 |
| 2024 | $0.00 | $-13.70M | $-1.22 |
| 2023 | $0.00 | $-34.36M | $-7.65 |
| 2022 | $0.00 | $-7.82M | $-23.20 |
| 2021 | $0.00 | $-35.82M | $-23.66 |
| 2020 | $0.00 | $-27.53M | $-73.50 |
| 2019 | $0.00 | $-37.04M | $-35.85 |
| 2018 | $0.00 | $-28.38M | $-33.10 |
Valuation
CALChas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
100Social Signal Score
Mentions (1)
- Newsglobenewswire.com·5h ago·Neutral
CalciMedica Announces One-for-Five Reverse Stock Split LA JOLLA, Calif., Aug. 27, 2026 (GLOBE NEWSWIRE) -- CalciMedica Inc. (“CalciMedica” or the “Company”) (Nasdaq: CALC), a clinical-stage biopharmaceutical company developing novel calcium release-activated calcium (CRAC) channel inhibition therapies for serious inflammatory, immunologic, and cardiopulmonary diseases, today announced that it will effect a reverse stock split of its issued and outstanding common stock, at a ratio of 1-for-5, eff…
View source ↗
Earnings
Wed, Nov 11(in 3 months)
Consensus estimate $-0.26 per share
Typical surprise -7.1% (median, so one quarter with a near-zero estimate can't distort it)
- Tue, Aug 11$-0.45 vs $-0.28miss
- Tue, May 12$-0.30 vs $-0.28miss
- Tue, Mar 3$-0.68 vs $-0.55miss
- Wed, Nov 12$-0.52 vs $-0.41miss
- Tue, Aug 12$-0.40 vs $-0.40beat
- Wed, May 14$-0.36 vs $-0.43beat
Estimates and results for CALC via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by CALC officers and directors.
- Bought
- $451k
- Sold
- $4k
30 trades
1 trade
- Middleton Fred Abought
- Roberts Eric Wbought
- Roberts Eric Wbought
- Roberts Eric Wbought
- Roberts Eric Wbought
- Roberts Eric Wbought
- Roberts Eric Wbought
- Roberts Eric Wbought
69 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.